1623 Capital LLC Avrobio, Inc. Transaction History

1623 Capital LLC

  • $0
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$3.45 - $6.05 $63,752 - $111,797
-18,479 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.53 - $9.28 $38,710 - $64,959
7,000 Added 60.98%
18,479 $103,000
Q2 2021

Aug 13, 2021
BUY
$7.84 - $12.6 $42,406 - $68,153
5,409 Added 89.11%
11,479 $102,000
Q1 2021

May 14, 2021
BUY
$10.54 - $19.3 $63,977 - $117,151
6,070 New
6,070 $77,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track 1623 Capital LLC Portfolio

Follow 1623 Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1623 Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1623 Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email